Clinical Trial Update: Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating salvage radiation therapy plus enzalutamide after prostatectomy for prostate cancer; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xtandi (enzalutamide)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Adenocarcinoma of the Prostate | Phase 2 | Status: COMPLETED | Results posted: 2025-10-24